Cultural sensitivity, communication key to strengthening India's medical tourism appeal: IIM experts

Experts highlight cultural sensitivity and communication's importance for international medical tourists. Effective expectation management and communication enhance patient experiences in Indian hospitals. India is a leading medical tourism destination due to advanced healthcare and affordable costs. Hospitals should invest in intercultural communication training for professionals. Bridging cultural gaps improves patient satisfaction and India's market competitiveness.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OCSImb8
via IFTTT

Read More

Navi Mumbai Airport notified as port for import of drugs under Drugs Rules

Navi Mumbai Airport has been designated as a port for drug imports, a decision that boosts the pharmaceutical supply chain and simplifies trade activities. Following the amendment to Drugs Rules, 1945, the total number of notified ports has increased to 42. This initiative is aimed at facilitating efficient movement of pharmaceutical goods and enhancing regulatory oversight, showcasing the government's dedication to improving trade dynamics.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AWFJEtN
via IFTTT

Read More

Regulator seeks views to curb similar sounding drug brands

The Central Drugs Standard Control Organisation in India is inviting public contributions concerning new regulations aimed at curbing the sale of various medications under similar brand names, which can mislead both patients and pharmacists about their contents. As part of this initiative, the drug regulator has released a notice for stakeholder observations, with a deadline for comments set for July 17 to ensure improved safety and trust among patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nTO3oJP
via IFTTT

Read More

India's wellness industry poised for growth amid focus on preventive healthcare, rising income: EBG Group chief

India's wellness market, valued at over $150 billion, is set for growth fueled by rising health consciousness and disposable incomes. EBG Group is launching Carlton Wellness India, an integrated ecosystem blending traditional Indian healing with modern hospitality. This platform will offer diverse wellness experiences, from city centers to retreats, emphasizing preventive care and holistic wellbeing for everyday life.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WPFLkpU
via IFTTT

Read More

Gene therapy firm Immuneel ties up with Arogya Finance to offer Rs 25 lakh zero-cost EMI for cancer treatment

Immuneel Therapeutics collaborates with Arogya Finance to unveil a zero-cost EMI scheme for advanced cancer treatments, providing support of up to Rs 25 lakh. This effort is a segment of Immuneel's Saksham Patient Access Program, letting eligible patients benefit from interest-free installments for as long as 12 months, thereby reducing financial pressures and facilitating prompt access to essential therapies for those in need.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9GLTgKS
via IFTTT

Read More

Glenmark launches generic Olanzapine injection in US

Glenmark Pharmaceuticals has launched a generic version of Olanzapine injection in the United States, offering a treatment for schizophrenia and bipolar disorder. This move by its US arm, Glenmark Pharmaceuticals Inc., introduces a bioequivalent alternative to Zyprexa intramuscular injection. The company aims to expand its injectable offerings and bolster its presence in the institutional market, targeting a segment with significant annual sales.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/cZKjp6i
via IFTTT

Read More

Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcare

Five young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials contained only water, not the active ingredient. The manufacturer, Jackson Laboratories, has had stop-production orders earlier as well. This incident has put focus on critical failures in drug regulation and raises serious concerns about patient safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/iaItPh9
via IFTTT

Read More